Intuitive Surgical (NASDAQ:ISRG) had its price target lifted by analysts at Royal Bank of Canada to $430.00 in a research report issued on Friday, The Fly reports. The firm presently has a “sector perform” rating on the medical equipment provider’s stock. Royal Bank of Canada’s price target would indicate a potential downside of 4.40% from the stock’s current price.
A number of other research analysts have also recently issued reports on the stock. Wedbush reaffirmed a “buy” rating on shares of Intuitive Surgical in a report on Tuesday, October 10th. Zacks Investment Research raised shares of Intuitive Surgical from a “hold” rating to a “strong-buy” rating and set a $437.00 price target for the company in a report on Tuesday, December 12th. ValuEngine cut shares of Intuitive Surgical from a “hold” rating to a “sell” rating in a report on Friday, December 29th. Goldman Sachs Group reissued a “buy” rating on shares of Intuitive Surgical in a report on Saturday, November 18th. Finally, Barclays reissued an “overweight” rating on shares of Intuitive Surgical in a report on Friday, October 20th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating, fourteen have issued a buy rating and one has issued a strong buy rating to the company. The company presently has an average rating of “Buy” and a consensus target price of $400.97.
Intuitive Surgical (ISRG) opened at $449.81 on Friday. The stock has a market cap of $50,400.00, a price-to-earnings ratio of 58.11, a price-to-earnings-growth ratio of 5.22 and a beta of 0.47. Intuitive Surgical has a fifty-two week low of $227.38 and a fifty-two week high of $452.00.
In related news, VP Jamie Samath sold 959 shares of the firm’s stock in a transaction on Friday, December 1st. The shares were sold at an average price of $398.46, for a total transaction of $382,123.14. Following the sale, the vice president now owns 536 shares in the company, valued at $213,574.56. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CFO Marshall Mohr sold 6,000 shares of the firm’s stock in a transaction on Monday, October 30th. The shares were sold at an average price of $372.22, for a total transaction of $2,233,320.00. Following the sale, the chief financial officer now owns 12,316 shares in the company, valued at approximately $4,584,261.52. The disclosure for this sale can be found here. In the last three months, insiders have sold 28,621 shares of company stock valued at $11,216,568. 2.20% of the stock is currently owned by corporate insiders.
A number of hedge funds have recently added to or reduced their stakes in the stock. Edgewood Management LLC grew its position in Intuitive Surgical by 200.7% during the third quarter. Edgewood Management LLC now owns 2,898,113 shares of the medical equipment provider’s stock valued at $1,010,359,000 after buying an additional 1,934,382 shares during the period. Koch Industries Inc. grew its position in Intuitive Surgical by 202,917.0% during the second quarter. Koch Industries Inc. now owns 1,388,636 shares of the medical equipment provider’s stock valued at $1,387,000 after buying an additional 1,387,952 shares during the period. Janus Henderson Group PLC grew its position in Intuitive Surgical by 42.0% during the third quarter. Janus Henderson Group PLC now owns 585,196 shares of the medical equipment provider’s stock valued at $612,042,000 after buying an additional 173,026 shares during the period. Schwab Charles Investment Management Inc. grew its position in Intuitive Surgical by 214.2% during the fourth quarter. Schwab Charles Investment Management Inc. now owns 386,037 shares of the medical equipment provider’s stock valued at $140,881,000 after buying an additional 263,157 shares during the period. Finally, APG Asset Management N.V. grew its position in Intuitive Surgical by 318.4% during the fourth quarter. APG Asset Management N.V. now owns 363,539 shares of the medical equipment provider’s stock valued at $110,485,000 after buying an additional 276,657 shares during the period. Institutional investors own 33.11% of the company’s stock.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
